Man Group’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $767K | Buy |
+35,239
| New | +$682K | ﹤0.01% | 1926 |
|
|
2025
Q2 | – | Sell |
-14,001
| Closed | -$894K | – | 2374 |
|
|
2025
Q1 | $894K | Buy |
+14,001
| New | +$1.47M | ﹤0.01% | 1613 |
|
|
2024
Q4 | – | Sell |
-311,338
| Closed | -$38.9M | – | 2191 |
|
|
2024
Q3 | $38.9M | Sell |
311,338
-75,086
| -19% | -$10.4M | 0.11% | 256 |
|
|
2024
Q2 | $61.1M | Buy |
386,424
+266,419
| +222% | +$34.2M | 0.16% | 153 |
|
|
2024
Q1 | $15.5M | Buy |
+120,005
| New | +$14.7M | 0.04% | 519 |
|
|
2023
Q2 | – | Hold |
0
| – | -$216K | – | 2211 |
|
|
2023
Q1 | – | Sell |
-81,744
| Closed | -$10.6M | – | 1780 |
|
|
2022
Q4 | $10.6M | Buy |
81,744
+10,344
| +14% | +$1.2M | 0.04% | 541 |
|
|
2022
Q3 | $7.89M | Buy |
+71,400
| New | +$7.2M | 0.04% | 563 |
|
|
2022
Q2 | – | Sell |
-16,519
| Closed | -$1.22M | – | 1681 |
|
|
2022
Q1 | $1.29M | Buy |
+16,519
| New | +$1.27M | ﹤0.01% | 1312 |
|
|
2021
Q4 | – | Sell |
-31,819
| Closed | -$2.94M | – | 2097 |
|
|
2021
Q3 | $2.94M | Buy |
31,819
+14,063
| +79% | +$1.08M | 0.01% | 1046 |
|
|
2021
Q2 | $1.38M | Buy |
17,756
+7,498
| +73% | +$568K | ﹤0.01% | 1318 |
|
|
2021
Q1 | $765K | Buy |
10,258
+22
| +0.2% | +$2.03K | ﹤0.01% | 1362 |
|
|
2020
Q4 | $1.75M | Sell |
10,236
-30,177
| -75% | -$4.47M | 0.01% | 1249 |
|
|
2020
Q3 | $5.68M | Sell |
40,413
-2,038
| -5% | -$310K | 0.02% | 746 |
|
|
2020
Q2 | $6.81M | Buy |
+42,451
| New | +$5.78M | 0.03% | 525 |
|
|
2019
Q4 | – | Sell |
-17,254
| Closed | -$1.3M | – | 1908 |
|
|
2019
Q3 | $1.3M | Sell |
17,254
-14,446
| -46% | -$1.71M | ﹤0.01% | 1371 |
|
|
2019
Q2 | $4.82M | Sell |
31,700
-8,082
| -20% | -$982K | 0.02% | 965 |
|
|
2019
Q1 | $4.74M | Buy |
39,782
+37,282
| +1,491% | +$4.79M | 0.02% | 952 |
|
|
2018
Q4 | $273K | Sell |
2,500
-6,435
| -72% | -$805K | ﹤0.01% | 1756 |
|
|
2018
Q3 | $1.44M | Buy |
8,935
+6,435
| +257% | +$880K | 0.01% | 1528 |
|
|
2018
Q2 | $330K | Buy |
+2,500
| New | +$236K | ﹤0.01% | 1900 |
|
Other funds holding SRPT
VPM
VCM
RCM
EAM
